Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Cave, H" or (type any "bookEditor issueEditor" and editor="Cave, H")

Add to list
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, et al.

(2018) LEUKEMIA. 32(1). p.244-248
Add to list
Exploring the long non-coding RNA landscape in juvenile myelomonocytic leukemia

Mattias Hofmans (UGent) , Tim Lammens (UGent) , S Bresolin, H Cavé, C Flotho, H Hasle, Hetty Helsmoortel (UGent) , M Van den Heuvel-Eibrink, C Niemeyer, J Stary, et al.

(2018) Abstracts BHS general annual meeting 2018. p.13-14
Add to list
The long non-coding RNA H19 is regulated by LIN28B

Hetty Helsmoortel (UGent) , Barbara De Moerloose (UGent) , Tim Pieters (UGent) , Farzaneh Ghazavi (UGent) , S Bresolin, H Cavé, A Caye, ACH de Vries, C Flotho, V Labarque, et al.

(2015) HAEMATOLOGICA. 100(suppl. 2). p.5-6
Add to list
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951

E Clappier, N Grardel, M Bakkus, J Rapion, Barbara De Moerloose (UGent) , P Kastner, A Caye, J Vivent, V Costa, A Ferster, et al.

(2015) LEUKEMIA. 29(11). p.2154-2161
Add to list
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions

E Clappier, M-F Auclerc, J Rapion, M Bakkus, A Caye, A Khemiri, C Giroux, L Hernandez, E Kabongo, S Savola, et al.

(2014) LEUKEMIA. 28(1). p.70-77
Add to list
- Journal Article
- A1
Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies

A Renneville, S Kaltenbach, E Clappier, S Collette, JB Micol, B Nelken, P Lepelley, N Dastugue, Yves Benoit (UGent) , Y Bertrand, et al.

(2010) LEUKEMIA. 24(2). p.476-480
Add to list
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

E Clappier, S Collette, N Grardel, S Girard, L Suarez, G Brunie, S Kaltenbach, K Yakouben, F Mazingue, A Robert, et al.

(2010) LEUKEMIA. 24(12). p.2023-2031
Add to list
- Journal Article
- A1
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, V Asnafi, A Baruchel, R Bassan, Yves Benoit (UGent) , et al.

(2009) Leukemia. 24(3). p.521-535
Add to list
- Miscellaneous
Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q(10) deficiency

A AEBY, Y SZNAJER, H CAVÉ, E REBUFFAT, Rudy Van Coster (UGent) , O RIGAL and P VAN BOGAERT

(2007) JOURNAL OF INHERITED METABOLIC DISEASE. 30(5). p.827-827
Add to list
- Journal Article
- A1
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCR β-HOXA rearrangement : a study of the Groupe Francophone de Cytogénétique Hématologique

Barbara Cauwelier, H Cavé, C Gervais, M Lessard, C Barin, C Perot, J Van den Akker, F Mugneret, C Charrin, MP Pagès, et al.

(2007) LEUKEMIA. 21(1). p.121-128

Academic Bibliography

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

Exploring the long non-coding RNA landscape in juvenile myelomonocytic leukemia

The long non-coding RNA H19 is regulated by LIN28B

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions

Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q(10) deficiency

Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCR β-HOXA rearrangement : a study of the Groupe Francophone de Cytogénétique Hématologique

Contents

Support

Contact